MedTrace Logo

Folic Acid Interferes With Radiation Esophagitis

NCT05296369 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2022-03-25

No results posted yet for this study

Summary

This randomized study compared the incidence and severity of radiation esophagitis with folic acid and with conventional symptomatic treatment.

Conditions

Interventions

DRUG

Folic acid

Folic acid was added during the period prior to concurrent chemoradiotherapy

Sponsors & Collaborators

  • Guizhou Medical University

    lead OTHER

Principal Investigators

  • Bing Lu, MD · The affiliated Cancer Hospital of Guizhou Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05296369 on ClinicalTrials.gov